Metraipolis › archive › dc_07b9962bd29d
Gut Microbiota as an Innovative Therapeutic Target in Cardiovascular Diseases from a Metabolic and Inflammatory Perspective — Europe PMC PMID:42351694
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42351694
- DOI
- 10.3390/biomedicines14061267
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T21:11:40.463Z
- SHA-256 of the archived text
1cabcfa5d06a32fc51d1a15971df77577409be663eb6e576ab786dbec233b71c- Stable URL of this page
https://metraipolis.com/documento/dc_07b9962bd29d
How to cite
Gut Microbiota as an Innovative Therapeutic Target in Cardiovascular Diseases from a Metabolic and Inflammatory Perspective — Europe PMC PMID:42351694 — Europe PMC (en), https://europepmc.org/article/MED/42351694 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07b9962bd29d (Metraipolis archive dc_07b9962bd29d, sha256 1cabcfa5d06a32fc51d1a15971df77577409be663eb6e576ab786dbec233b71c)
BibTeX
@misc{dc07b9962bd29d,
title = {Gut Microbiota as an Innovative Therapeutic Target in Cardiovascular Diseases from a Metabolic and Inflammatory Perspective — Europe PMC PMID:42351694},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42351694},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07b9962bd29d; sha256 1cabcfa5d06a32fc51d1a15971df77577409be663eb6e576ab786dbec233b71c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42351694. Agents can read the archived copy with the MCP tool read_document.